Loading…

Predicting risk for bisphosphonate-related osteonecrosis of the jaws: CTX versus radiographic markers

Background and objective The most common risk factor for bisphosphonate-related osteonecrosis of the jaws (BRONJ) is dentoalveolar surgery. It has been suggested that reduced serum C-terminal telopeptide (CTX) can determine the degree of osteoclast suppression and may predict the development of BRON...

Full description

Saved in:
Bibliographic Details
Published in:Oral surgery, oral medicine, oral pathology, oral radiology and endodontics oral medicine, oral pathology, oral radiology and endodontics, 2010-10, Vol.110 (4), p.509-516
Main Authors: Fleisher, Kenneth E., DDS, Welch, Garrett, Kottal, Shailesh, DDS, Craig, Ronald G., DMD, PhD, Saxena, Deepak, MS, PhD, Glickman, Robert S., DMD
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background and objective The most common risk factor for bisphosphonate-related osteonecrosis of the jaws (BRONJ) is dentoalveolar surgery. It has been suggested that reduced serum C-terminal telopeptide (CTX) can determine the degree of osteoclast suppression and may predict the development of BRONJ after dentoalveolar surgery. Although there are many radiographic appearances associated with BRONJ, there are little data that describes changes preceding dentoalveolar surgery. The objective of this retrospective study was: 1) to investigate if reduced serum CTX values (i.e.,
ISSN:1079-2104
1528-395X
DOI:10.1016/j.tripleo.2010.04.023